Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Isolated hyperCKemia is a condition characterized by elevated levels of an enzyme called creatine kinase in the blood. In affected individuals, levels of this enzyme are typically 3 to 10 times higher than normal. While elevated creatine kinase often accompanies various muscle diseases, individuals with isolated hyperCKemia have no muscle weakness or other symptoms. Some people with this condition have abnormalities of muscle cells that can be seen with a microscope, such as unusual variability in the size of muscle fibers, but these changes do not affect the function of the muscle.
Biomarker and diagnostic research for isolated asymptomatic elevation of creatine phosphokinase has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for isolated asymptomatic elevation of creatine phosphokinase.
17 publications have been identified in PubMed for isolated asymptomatic elevation of creatine phosphokinase. Research spans Case Report / Case Series (35%), Review / Meta-Analysis (24%), and Clinical Trial Publication (12%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 6 | 35% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 12:31 AM UTC
European rare disease database
Research summaries |
4 |
24% |
Clinical study results | 2 | 12% |
Laboratory research | 2 | 12% |
Disease patterns and progression | 2 | 12% |
Testing and diagnosis research | 1 | 6% |
Johari M (2026). [PMID: 41678358](https://pubmed.ncbi.nlm.nih.gov/41678358/). *Brain : a journal of neurology*. [Case Report / Case Series]
Luo X (2026). [PMID: 41734457](https://pubmed.ncbi.nlm.nih.gov/41734457/). *Endocrinology, diabetes & metabolism case reports*. [Case Report / Case Series]
Smaili F (2026). [PMID: 41677014](https://pubmed.ncbi.nlm.nih.gov/41677014/). *Biomolecules & biomedicine*. [Review / Meta-Analysis]
Li X (2025). [PMID: 41361093](https://pubmed.ncbi.nlm.nih.gov/41361093/). *Drugs in R&D*. [Case Report / Case Series]
Badri M (2025). [PMID: 40615888](https://pubmed.ncbi.nlm.nih.gov/40615888/). *Journal of medical case reports*. [Case Report / Case Series]
Skolka MP (2025). [PMID: 40315785](https://pubmed.ncbi.nlm.nih.gov/40315785/). *Neuromuscular disorders : NMD*. [Review / Meta-Analysis]
Dumas R (2025). [PMID: 40905397](https://pubmed.ncbi.nlm.nih.gov/40905397/). *European journal of neurology*. [Clinical Trial Publication]
Sekulic A (2025). [PMID: 40359611](https://pubmed.ncbi.nlm.nih.gov/40359611/). *Clinical neurology and neurosurgery*. [Diagnostic / Biomarker]
Mettananda S (2025). [PMID: 41136957](https://pubmed.ncbi.nlm.nih.gov/41136957/). *BMC pediatrics*. [Case Report / Case Series]
Johari M (2025). [PMID: 40666348](https://pubmed.ncbi.nlm.nih.gov/40666348/). *medRxiv : the preprint server for health sciences*. [Basic Science / Preclinical]